期刊
CLINICAL & EXPERIMENTAL METASTASIS
卷 33, 期 3, 页码 249-261出版社
SPRINGER
DOI: 10.1007/s10585-015-9775-5
关键词
Breast cancer; Mena; Hypoxia; Stemness; Microenvironment; Metastasis
类别
资金
- Department of Defense Breast Cancer Research Program [W81XWH-10-1-0040, W81XWH-13-1-0031]
- NIH Grant [U54-CA112967, GM58801]
- Ludwig Center at MIT
- KI NCI Core Grant [P30-CA14051, CA150344, CA100324]
Several functionally distinct isoforms of the actin regulatory Mena are produced by alternative splicing during tumor progression. Forced expression of the Mena(INV) isoform drives invasion, intravasation and metastasis. However, the abundance and distribution of endogenously expressed Mena(INV) within primary tumors during progression remain unknown, as most studies to date have only assessed relative mRNA levels from dissociated tumor samples. We have developed a Mena(INV) isoform-specific monoclonal antibody and used it to examine Mena(INV) expression patterns in mouse mammary and human breast tumors. Mena(INV) expression increases during tumor progression and to examine the relationship between Mena(INV) expression and markers for epithelial or mesenchymal status, stemness, stromal cell types and hypoxic regions. Further, while Mena(INV) robustly expressed in vascularized areas of the tumor, it is not confined to cells adjacent to blood vessels. Altogether, these data demonstrate the specificity and utility of the anti-Mena(INV)-isoform specific antibody, and provide the first description of endogenous Mena(INV) protein expression in mouse and human tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据